Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Otelixizumab> ?p ?o }
Showing triples 1 to 70 of
70
with 100 triples per page.
- Otelixizumab abstract "Otelixizumab, also known as TRX4, is a monoclonal antibody, which is being developed for the treatment of type 1 diabetes and other autoimmune diseases. The antibody is being developed by Tolerx, Inc. in collaboration with GlaxoSmithKline and is being manufactured by Abbott Laboratories.".
- Otelixizumab atcPrefix "none".
- Otelixizumab casNumber "881191-44-2".
- Otelixizumab fdaUniiCode "I5HF2X04PB".
- Otelixizumab wikiPageID "12478287".
- Otelixizumab wikiPageLength "5803".
- Otelixizumab wikiPageOutDegree "19".
- Otelixizumab wikiPageRevisionID "707385502".
- Otelixizumab wikiPageWikiLink Abbott_Laboratories.
- Otelixizumab wikiPageWikiLink B_cell.
- Otelixizumab wikiPageWikiLink C-peptide.
- Otelixizumab wikiPageWikiLink CD3_(immunology).
- Otelixizumab wikiPageWikiLink Category:Monoclonal_antibodies.
- Otelixizumab wikiPageWikiLink Food_and_Drug_Administration.
- Otelixizumab wikiPageWikiLink Fusion_protein.
- Otelixizumab wikiPageWikiLink GlaxoSmithKline.
- Otelixizumab wikiPageWikiLink Humanized_antibody.
- Otelixizumab wikiPageWikiLink Immunoglobulin_G.
- Otelixizumab wikiPageWikiLink Immunoglobulin_heavy_chain.
- Otelixizumab wikiPageWikiLink Immunoglobulin_light_chain.
- Otelixizumab wikiPageWikiLink Investigational_New_Drug.
- Otelixizumab wikiPageWikiLink Monoclonal_antibody.
- Otelixizumab wikiPageWikiLink Orphan_drug.
- Otelixizumab wikiPageWikiLink T-cell_surface_glycoprotein_CD3_epsilon_chain.
- Otelixizumab wikiPageWikiLink T_cell_receptor.
- Otelixizumab wikiPageWikiLink Tolerx.
- Otelixizumab wikiPageWikiLinkText "Otelixizumab".
- Otelixizumab wikiPageWikiLinkText "otelixizumab".
- Otelixizumab atcPrefix "none".
- Otelixizumab c "6448".
- Otelixizumab casNumber "881191".
- Otelixizumab chemspiderid "none".
- Otelixizumab h "9954".
- Otelixizumab kegg "D08959".
- Otelixizumab mabType "mab".
- Otelixizumab molecularWeight "145.1".
- Otelixizumab n "1718".
- Otelixizumab o "2016".
- Otelixizumab s "42".
- Otelixizumab source "xizu/a".
- Otelixizumab target T-cell_surface_glycoprotein_CD3_epsilon_chain.
- Otelixizumab type "mab".
- Otelixizumab unii "I5HF2X04PB".
- Otelixizumab verifiedfields "changed".
- Otelixizumab verifiedrevid "458269768".
- Otelixizumab wikiPageUsesTemplate Template:Cascite.
- Otelixizumab wikiPageUsesTemplate Template:Chemspidercite.
- Otelixizumab wikiPageUsesTemplate Template:Drugbox.
- Otelixizumab wikiPageUsesTemplate Template:Fdacite.
- Otelixizumab wikiPageUsesTemplate Template:Immunosuppressants.
- Otelixizumab wikiPageUsesTemplate Template:Keggcite.
- Otelixizumab wikiPageUsesTemplate Template:Monoclonals_for_immune_system.
- Otelixizumab wikiPageUsesTemplate Template:Reflist.
- Otelixizumab subject Category:Monoclonal_antibodies.
- Otelixizumab hypernym Antibody.
- Otelixizumab type ChemicalSubstance.
- Otelixizumab type Drug.
- Otelixizumab type Antibody.
- Otelixizumab type Chemical.
- Otelixizumab type Drug.
- Otelixizumab type ChemicalObject.
- Otelixizumab type Thing.
- Otelixizumab type Q8386.
- Otelixizumab comment "Otelixizumab, also known as TRX4, is a monoclonal antibody, which is being developed for the treatment of type 1 diabetes and other autoimmune diseases. The antibody is being developed by Tolerx, Inc. in collaboration with GlaxoSmithKline and is being manufactured by Abbott Laboratories.".
- Otelixizumab label "Otelixizumab".
- Otelixizumab sameAs Q7108506.
- Otelixizumab sameAs m.02w80td.
- Otelixizumab sameAs Q7108506.
- Otelixizumab wasDerivedFrom Otelixizumab?oldid=707385502.
- Otelixizumab isPrimaryTopicOf Otelixizumab.